The Role of Combination Maintenance with Pemetrexed and Bevacizumab for Advanced Stage Nonsquamous Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Biomed Res Int · 2018 · PMC5994575 · PMID 29998136

Europe PMC DOI

hedged sentence

0.6400

closest p · 12.8× alpha

0.6400

boldest claim

The sentences

a clear trendP = 0.64not close (p > 0.1)

As for overall survival, a clear trend for longer OS was observed in patients with age < 65 years (HR = 0.93, 95% CI = 0.69-1.26, P = 0.64), ECOG score = 0 (HR = 0.89, 95% CI = 0.69-1.14, P = 0.36), or never smoked (HR = 0.72, 95% CI = 0.45-1.17, P = 0.18).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.